New GFI1B variants in bleeding and platelet disorders

Platelets restrict blood loss upon vessel damage by formation of a clot (thrombus). Recently, we reported a family with a bleeding and platelet disorder (BPD), which was caused by a defect in the gene GFI1B1.

Computational Biology Training in Hematology Hall of Fame

Clinical Research Training in Hematology Hall of Fame

Translational Research Training in Hematology Hall of Fame

EHA-EMBL/EBI Computational Biology Training in Hematology

 The CBTH 2025 call for applications is open until August 30, 2024.

EU funding crucial in allowing medical researchers across member states to collaborate in the development of new treatments

In an article published in Science|Business, Prof.

Major bleeding in patients on treatment with NOACs or VKAs in real-life: clinical presentation, management and outcome

Major bleeding in patients on treatment with NOACs or VKAs in real-life: clinical presentation, management and outcome

Limited data are available on major bleeding (MB) occurring during treatment with vitamin K (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs) outside clinical…

About us

Welcome to the family! Get to know the YoungEHA Committee and learn how you can make a difference. Join YoungEHA through a junior membership. Meet the YoungEHA committee members:

 
 
Name: Mandy N.

Challenges and opportunities in the diagnostics and management of onco-hematological patients under the microscope during tutorial in Russia

Onco-hematology was the focus of the two-day EHA Hematology Tutorial in Moscow, Russia, the third joint tutorial organized by EHA, the National Hematological Society (NHS) and the Russian-Oncohematology Society (ROHS).